Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study

caglar yagci, hanife; Yagci, Ilker; bağcıer, fatih

doi:10.5606/tftrd.2023.12106

Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study

Hanife ÇAĞLAR YAĞCI, (Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi, Fizik Tedavi ve Rehabilitasyon Kliniği, İstanbul, Türkiye)

İlker YAĞCI, (Marmara Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, İstanbul, Türkiye)

Fatih BAĞCIER (Çam ve Sakura Şehir Hastanesi, Fiziksel Tıp ve Rehabilitasyon Bölümü, İstanbul, Türkiye)

Turkish Journal of Physical Medicine and Rehabilitation

3 1

Yıl: 2023 Cilt: 69 Sayı: 2 Sayfa Aralığı: 180 - 187 Metin Dili: İngilizce DOI: 10.5606/tftrd.2023.12106 İndeks Tarihi: 10-07-2023

Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study

Öz:

Objectives: The aim of this study was to compare the efficacy of the corticosteroid (CS) injection and shock wave therapy (SWT) in the treatment of greater trochanteric pain syndrome (GTPS). Patients and methods: Between 2020 September and 2021 October, a total of 60 patients with GTPS (12 males, 48 females; mean age: 50.8±8.5 years; range, 34 to 65 years) were included. The patients were randomly assigned to two groups as the SWT group (n=32) receiving one session of SWT per week for a total of three weeks and CS injection group (n=28) receiving CS and local anesthetic. Both groups were evaluated using the Short Form-36 (SF-36) at baseline and three months and using the Visual Analog Scale (VAS) and Western Ontario and McMaster University Osteoarthritis Index (WOMAC) at baseline, three weeks, and three months. Results: The mean VAS, greater trochanter tenderness, and WOMAC scores of both groups were similar at baseline, while the third-week and three-month scores were significantly lower in both groups compared to baseline (p<0.05). There was no significant difference in the treatment efficacy between the groups (p>0.05). There was a similar improvement in SF-36 physical function, physical role difficulty, and pain subscales in both groups (p<0.05). Conclusion: Our study results show that both CS injection and SWT are effective modalities and none of the treatments is superior to each other.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Segal NA, Felson DT, Torner JC, Zhu Y, Curtis JR, Niu J, et al. Greater trochanteric pain syndrome: Epidemiology and associated factors. Arch Phys Med Rehabil 2007;88:988-92. doi: 10.1016/j.apmr.2007.04.014.
2. Ho GW, Howard TM. Greater trochanteric pain syndrome: More than bursitis and iliotibial tract friction. Curr Sports Med Rep 2012;11:232-8. doi: 10.1249/ JSR.0b013e3182698f47.
3. Blankenbaker DG, Ullrick SR, Davis KW, De Smet AA, Haaland B, Fine JP. Correlation of MRI findings with clinical findings of trochanteric pain syndrome. Skeletal Radiol 2008;37:903-9. doi: 10.1007/s00256-008-0514-8.
4. Long SS, Surrey DE, Nazarian LN. Sonography of greater trochanteric pain syndrome and the rarity of primary bursitis. AJR Am J Roentgenol 2013;201:1083-6. doi: 10.2214/AJR.12.10038.
5. Mallow M, Nazarian LN. Greater trochanteric pain syndrome diagnosis and treatment. Phys Med Rehabil Clin N Am 2014;25:279-89. doi: 10.1016/j.pmr.2014.01.009.
6. Williams BS, Cohen SP. Greater trochanteric pain syndrome: A review of anatomy, diagnosis and treatment. Anesth Analg 2009;108:1662-70. doi: 10.1213/ane.0b013e31819d6562.
7. Barratt PA, Brookes N, Newson A. Conservative treatments for greater trochanteric pain syndrome: A systematic review. Br J Sports Med 2017;51:97-104. doi: 10.1136/ bjsports-2015-095858.
8. Mulligan EP, Middleton EF, Brunette M. Evaluation and management of greater trochanter pain syndrome. Phys Ther Sport 2015;16:205-14. doi: 10.1016/j. ptsp.2014.11.002.
9. Brinks A, van Rijn RM, Willemsen SP, Bohnen AM, Verhaar JA, Koes BW, et al. Corticosteroid injections for greater trochanteric pain syndrome: A randomized controlled trial in primary care. Ann Fam Med 2011;9:226-34. doi: 10.1370/ afm.1232.
10. Cohen SP, Strassels SA, Foster L, Marvel J, Williams K, Crooks M, et al. Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: Multicentre randomised controlled trial. BMJ 2009;338:b1088. doi: 10.1136/bmj.b1088.
11. Shbeeb MI, O'Duffy JD, Michet CJ Jr, O'Fallon WM, Matteson EL. Evaluation of glucocorticosteroid injection for the treatment of trochanteric bursitis. J Rheumatol 1996;23:2104-6.
12. Furia JP, Rompe JD, Maffulli N. Low-energy extracorporeal shock wave therapy as a treatment for greater trochanteric pain syndrome. Am J Sports Med 2009;37:1806-13. doi: 10.1177/0363546509333014.
13. Rompe JD, Segal NA, Cacchio A, Furia JP, Morral A, Maffulli N. Home training, local corticosteroid injection, or radial shock wave therapy for greater trochanter pain syndrome. Am J Sports Med 2009;37:1981-90. doi: 10.1177/0363546509334374.
14. Doig GS, Simpson F. Randomization and allocation concealment: A practical guide for researchers. J Crit Care 2005;20:187-93. doi: 10.1016/j.jcrc.2005.04.005.
15. Tüzün EH, Eker L, Aytar A, Daşkapan A, Bayramoğlu M. Acceptability, reliability, validity and responsiveness of the Turkish version of WOMAC osteoarthritis index. Osteoarthritis Cartilage 2005;13:28-33. doi: 10.1016/j. joca.2004.10.010.
16. Nissen MJ, Brulhart L, Faundez A, Finckh A, Courvoisier DS, Genevay S. Glucocorticoid injections for greater trochanteric pain syndrome: A randomised double-blind placebo-controlled (GLUTEAL) trial. Clin Rheumatol 2019;38:647-55. doi: 10.1007/s10067-018-4309-6.
17. Koçyiğit H, Aydemir O, Fişek G, Ölmez N, Memiş A. Kısa Form-36 (SF-36)'nın Türkçe versiyonunun güvenilirliği ve geçerliliği. İlaç ve Tedavi Dergisi 1999;12:102-6.
18. Brinks A, van Rijn RM, Willemsen SP, Bohnen AM, Verhaar JA, Koes BW, et al. Corticosteroid injections for greater trochanteric pain syndrome: A randomized controlled trial in primary care. Ann Fam Med 2011;9:226-34. doi: 10.1370/ afm.1232.
19. Carlisi E, Cecini M, Di Natali G, Manzoni F, Tinelli C, Lisi C. Focused extracorporeal shock wave therapy for greater trochanteric pain syndrome with gluteal tendinopathy: A randomized controlled trial. Clin Rehabil 2019;33:670-80. doi: 10.1177/0269215518819255.
20. Ramon S, Russo S, Santoboni F, Lucenteforte G, Di Luise C, de Unzurrunzaga R, et al. Focused shockwave treatment for greater trochanteric pain syndrome: A multicenter, randomized, controlled clinical trial. J Bone Joint Surg [Am] 2020;102:1305-11. doi: 10.2106/ JBJS.20.00093.
21. Seo KH, Lee JY, Yoon K, Do JG, Park HJ, Lee SY, et al. Longterm outcome of low-energy extracorporeal shockwave therapy on gluteal tendinopathy documented by magnetic resonance imaging. PLoS One 2018;13:e0197460. doi: 10.1371/journal.pone.0197460.
22. Wheeler PC, Dudson C, Calver R, Goodall D, Gregory KM, Singh H, et al. Three sessions of radial extracorporeal shockwave therapy gives no additional benefit over "minimal-dose" radial extracorporeal shockwave therapy for patients with chronic greater trochanteric pain syndrome: A double-blinded, randomized, controlled trial. Clin J Sport Med 2022;32:e7-18. doi: 10.1097/JSM.0000000000000880.
23. Sconfienza LM, Adriaensen M, Alcala-Galiano A, Allen G, Aparisi Gómez MP, Aringhieri G, et al. Clinical indications for image-guided interventional procedures in the musculoskeletal system: A Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)-part IV, hip. Eur Radiol 2022;32:551-60. doi: 10.1007/s00330-021-07997-5.
24. Sultan J, Lovell ME. Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome. MOJ Orthop Rheumatol 2015;2:102-4. doi: 10.15406/ mojor.2015.02.00050.

APA	caglar yagci h, Yagci I, bağcıer f (2023). Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. , 180 - 187. 10.5606/tftrd.2023.12106
Chicago	caglar yagci hanife,Yagci Ilker,bağcıer fatih Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. (2023): 180 - 187. 10.5606/tftrd.2023.12106
MLA	caglar yagci hanife,Yagci Ilker,bağcıer fatih Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. , 2023, ss.180 - 187. 10.5606/tftrd.2023.12106
AMA	caglar yagci h,Yagci I,bağcıer f Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. . 2023; 180 - 187. 10.5606/tftrd.2023.12106
Vancouver	caglar yagci h,Yagci I,bağcıer f Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. . 2023; 180 - 187. 10.5606/tftrd.2023.12106
IEEE	caglar yagci h,Yagci I,bağcıer f "Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study." , ss.180 - 187, 2023. 10.5606/tftrd.2023.12106
ISNAD	caglar yagci, hanife vd. "Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study". (2023), 180-187. https://doi.org/10.5606/tftrd.2023.12106

APA	caglar yagci h, Yagci I, bağcıer f (2023). Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. Turkish Journal of Physical Medicine and Rehabilitation, 69(2), 180 - 187. 10.5606/tftrd.2023.12106
Chicago	caglar yagci hanife,Yagci Ilker,bağcıer fatih Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. Turkish Journal of Physical Medicine and Rehabilitation 69, no.2 (2023): 180 - 187. 10.5606/tftrd.2023.12106
MLA	caglar yagci hanife,Yagci Ilker,bağcıer fatih Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. Turkish Journal of Physical Medicine and Rehabilitation, vol.69, no.2, 2023, ss.180 - 187. 10.5606/tftrd.2023.12106
AMA	caglar yagci h,Yagci I,bağcıer f Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. Turkish Journal of Physical Medicine and Rehabilitation. 2023; 69(2): 180 - 187. 10.5606/tftrd.2023.12106
Vancouver	caglar yagci h,Yagci I,bağcıer f Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study. Turkish Journal of Physical Medicine and Rehabilitation. 2023; 69(2): 180 - 187. 10.5606/tftrd.2023.12106
IEEE	caglar yagci h,Yagci I,bağcıer f "Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study." Turkish Journal of Physical Medicine and Rehabilitation, 69, ss.180 - 187, 2023. 10.5606/tftrd.2023.12106
ISNAD	caglar yagci, hanife vd. "Comparison of shock wave therapy and corticosteroid injection in the treatment of greater trochanteric pain syndrome: A single-blind, randomized study". Turkish Journal of Physical Medicine and Rehabilitation 69/2 (2023), 180-187. https://doi.org/10.5606/tftrd.2023.12106